New clinician-guided program blends medical science, microdosing, and 24/7 support to make advanced weight loss and wellness ...

Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its ...

Counterfeit GLP-1's are emerging as a deadly public health threat. In the wake of one woman’s tragic death, another reveals ...

This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key ...

Weight-loss medicines like Semaglutide (GLP – 1RA), originally developed to help people with type 2 diabetes manage their ...

This article was reviewed by Darragh O’Carroll, MD. GLP-1 for Weight Loss: Everything You Need to Know Key takeaways: GLP-1s ...

Novo Nordisk is under pressure from cheap copycats, a Trump pricing deal, and Lilly's fast-growing Zepbound juggernaut.

Hims & Hers Health, Inc. could see more upside in partnerships and international expansion. Click here to read an analysis of ...

Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock are in focus as the companies are nearing to strike U.S. pricing deals for ...

Zydus Lifesciences Ltd and Torrent Pharmaceuticals Ltd are preparing to enter the fast-growing market for Semaglutide — a ...

How long would you need to jab yourself...and contend with the cost? Two MDs specializing in weight loss and endocrinology share how it works.

Hims & Hers Health (NYSE:HIMS) said it is holding discussions with Novo Nordisk (NYSE:NVO) to make the Danish drugmaker's ...